Categories
El Salvador joins the Alliance for Primary Health Care in the Americas
El Salvador joins the Alliance for Primary Health Care in the Americas
Cristina Mitchell
2 Dec 2024
Categories
Hemodialysis Correction: Baxter Issues Correction for AK 98 Hemodialysis Machines Due to Risk of Patient Exposure to Higher Than Allowable Levels of Toxic Compound NDL-PCBA and/or NDL-PCBs
Use of Baxter AK 98 hemodialysis machines with less than 500 hours of run time may expose patients to higher than allowable NDL-PCBAs.
Categories
Insertion Tube Recall: FHC Removes microTargeting Insertion Tube Sets due to a Manufacturing Size Error That May Lead to Patient Harm
FHC microTargeting Insertion Tube Sets guide instruments during neurosurgery. The reducing cannula in a specific lot is 20mm too long.
Categories
Biopsy Needle Recall: Elekta Removes Disposable Biopsy Needle Kits due to Risk of Microscopic Stainless Steel Debris Inside Needle
Disposable Biopsy Needle Kit is used in neurosurgery but a specific batch of kits may have microscopic stainless steel debris inside.
Categories
On World AIDS Day, PAHO launches Better with PrEP campaign
On World AIDS Day, PAHO launches Better with PrEP campaign
Cristina Mitchell
28 Nov 2024
Categories
PAHO calls on countries of the Americas to maintain Mpox surveillance and genomic sequencing
PAHO calls on countries of the Americas to maintain Mpox surveillance and genomic sequencing
Cristina Mitchell
26 Nov 2024
Categories
FDA Roundup: November 26, 2024
FDA Roundup: November 26, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-26-2024
Categories
At COP29, PAHO warns that failure to focus on people in vulnerable situations will exacerbate health inequities
At COP29, PAHO warns that failure to focus on people in vulnerable situations will exacerbate health inequities
Oscar Reyes
22 Nov 2024
Categories
FDA Roundup: November 22, 2024
FDA Roundup: November 22, 2024
http://www.fda.gov/news-events/press-announcements/fda-roundup-november-22-2024
Categories
Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole
MXBBB is voluntarily recalling 1 lot of UMARY ACID HYALURONIC, 30 CAPLETS 850 MG to the consumer level. The products have been found to have omeprazole and diclofenac. FDA laboratory analysis confirmed that Umary contains diclofenac and omeprazole
